Increased hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 in heterozygous familial hypercholesterolaemia: a stable isotope study Original Research Article

We have measured the hepatic secretion of very-low-density-lipoprotein apolipoprotein B-100 (VLDL apo B) in 6 patients with heterozygous familial hypercholesterolaemia (FH) (4 males, 2 females, age 47.0 ± 2.7 years (mean ± S.E.M.), weight 71.0 ± 5.3 kg) and 6 normocholesterolaemic subjects matched for age, weight and sex (4 males, 2 females, age 47.5 ± 3.1 years, weight 70.0 ± 4.4 kg) using a stable isotope method. Each subject received a primed, constant infusion of [1-13C]leucine and isotopic enrichment of VLDL apo B was determined using gaschromatography mass-spectrometry (GCMS). Mean plasma low-density-lipoprotein (LDL) cholesterol and apo B concentrations in the FH group were more than twice that in the control group (FH, 8.5 ± 0.5 mmol/l vs. controls, 3.3 ± 0.2 mmol/l, P < 0.001; and FH, 2.0 ± 0.1 g/l vs. controls, 1.0 ± 0.04 g/l, P < 0.0001, respectively). Plasma triglyceride (TG) and high-density-lipoprotein (HDL) cholesterol concentrations were not significantly different between the two groups. Although the fractional secretion rates of VLDL apo B were similar (FH, 14.3 ± 3.6 pools/day vs. controls, 11.6 ± 1.7 pools/day, P = 0.53), VLDL apo B pool size and VLDL apo B absolute secretion rates (ASR) were significantly higher in the FH group (FH, 234.2 ± 27.8 mg vs. controls, 66.3 ± 13.5 mg, P < 0.001; and FH, 51.4 ± 17.9 mg/kg per day vs. controls, 9.4 ± 1.1 mg/kg per day, P < 0.02, respectively). We conclude that FH is associated with increased hepatic secretion of VLDL apo B and that this may contribute to the elevated concentration of LDL-cholesterol. The findings are also consistent with the hypothesis that in FH increased hepatic cholesterol availability (due to increased uptake of LDL-cholesterol via the receptor-independent pathway) stimulates hepatic secretion of VLDL apo B.